切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2025, Vol. 18 ›› Issue (02) : 338 -340. doi: 10.3877/cma.j.issn.1674-6902.2025.02.026

病例报告

隐匿性甲状腺癌伴肺转移一例
黄家秀1, 古志明1, 柯行智1, 王超群2,()   
  1. 1. 570311 海口,海南医科大学第二附属医院核医学科
    2. 570311 海口,海南医科大学附属海南医院核医学科
  • 收稿日期:2025-02-12 出版日期:2025-04-25
  • 通信作者: 王超群

One case report: Occult thyroid cancer with lung metastasis

Jiaxiu Huang, Zhiming Gu, Xingzhi Ke, Chaoqun Wang()   

  • Received:2025-02-12 Published:2025-04-25
  • Corresponding author: Chaoqun Wang
引用本文:

黄家秀, 古志明, 柯行智, 王超群. 隐匿性甲状腺癌伴肺转移一例[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(02): 338-340.

Jiaxiu Huang, Zhiming Gu, Xingzhi Ke, Chaoqun Wang. One case report: Occult thyroid cancer with lung metastasis[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(02): 338-340.

图1 患者胸部CT、甲状腺超声、胸部PET/MR 及组织病理学检查结果。 图A、B 为胸部CT 肺组织窗可见双肺多个类圆形结节,边界清晰;图C 为甲状腺超声可见甲状腺双叶多个囊实性结节,边界清晰;图D 为胸部PET/MR 可见双肺多个高代谢结节;图E 为(左肺下叶肺)转移癌,形态及免疫表型考虑甲状腺来源(HE 染色,×200);图F 为(甲状腺左叶中上段结节)甲状腺滤泡增生性病变(HE 染色,×200)
图2 患者全身PET/MRA 检查结果。 图A、B 为治疗前131I 全身显像示双肺多发异常浓聚灶,考虑甲状腺癌双肺多发转移;图C、D 为治疗后131I 全身显像示颈部甲状腺残留组织已清除,肺部未见明显甲状腺癌转移灶
1
尹嘉晶,王任飞,曲 伸. 真实世界甲状腺癌的诊疗现状与思考[J]. 中国实用内科杂志,2022,42(11): 915-919.
2
韩 婧,康 骅. 甲状腺癌的发病现状及影响因素[J]. 实用预防医学,2018,25(7): 894-897.
3
Watkinson JC,Franklyn JA,Olliff JFC.Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer[J]. Thyroid,2006,16(2): 187-194.
4
Joanna KG,John C,Aneeta P,et al.Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer[J]. J Clin Endocrinol Metabol,2013(8): 3269-3279.
5
Werner RA ,Schmid JS,Muegge DO,et al. Prognostic value of serum tumor markers in medullary thyroid cancer patients undergoing vandetanib treatment[J]. Medicine,2015,94(45): e2016.
6
Williams GR. Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?[J]. J Endocrinol Invest,2014,37(8): 775-779.
7
Li D,Li J,Zhou J,et al. Metastatic papillary thyroid carcinoma with no primary tumor in the thyroid gland: a case report and review of literature[J]. Transl Cancer Res,2022,11(1): 299-305.
8
Boucek J,Kastner J,Skrivan J,et al. Occult thyroid carcinoma[J].Acta Otorhinolaryngol Ital,2009 ,29(6): 296-304.
9
Tagliabue M,Giugliano G,Mariani MC,et al. Prevalence of central compartment lymph node metastases in papillary thyroid microcarcinoma: a retrospective evaluation of predictive preoperative features[J]. Cancers (Basel),2021 ,13(23): 6028.
10
Saijo H,Kitamura Y,Takenaka H,et al. Occult thyroid follicular carcinoma diagnosed as metastasis to the chest wall[J]. Intern Med,2017,56(15): 2033-2037.
11
Liu H,Lv L,Yang K. Occult thyroid carcinoma: a rare case report and review of literature[J]. Int J Clin Exp Pathol,2014 ,7(8):5210-5214.
12
毛 骞. P16 表达与女性隐匿性甲状腺癌微转移的相关性研究[J]. 中国民康医学,2011,23(20): 2510-2525.
13
彭 琛. 1401 例甲状腺微小乳头状癌临床病理特征及中央区淋巴结转移危险因素分析[J]. 中国肿瘤临床,2016,43(3): 95-99.
14
Zhang N,Wang Z,Sun B,et al. An innovative approach for predicting the metastasis of central lymph nodes in papillary thyroid microcarcinoma: A nomogram based on clinical and ultrasonographic characteristics[J]. Indian J Cancer,2025,61(3): 645-653.
15
Isabela Matos da Silva,Taísa Quécia da Silva Nogueira,Deborah Nogueira Couto,et al. Feasibility of a snowball sampling survey to study active surveillance for thyroid microcarcinoma treatment among endocrinologists and surgeons of Brazil[J]. Braz J Otorhinolaryngol,2022,88( Suppl 4): S163-S169.
16
于 淏,王 强,查斯洛,等. 5 mm 及以下cN0 甲状腺乳头状微小癌中央区淋巴结转移规律及危险因素分析[J]. 第二军医大学学报,2018,39(1): 101-104.
17
黄益龙,赵 雯,李浚利,等. 双能CT 碘图评估甲状腺微小乳头状癌颈淋巴结转移潜能的价值[J]. 中华放射学杂志,2019,53(8): 655-660.
18
Yamamoto M,Miyauchi A,Kudo ST. Active surveillance outcomes of patients with low-risk papillary thyroid microcarcinoma according to levothyroxine treatment status[J].Thyroid,2023,33(10):1182-1189.
19
Tran A,Weigel RJ,Beck AC. ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence[J]. Am J Surg,2024,229: 106-110.
20
Kim K,Choi JY,Kim SJ,et al. Active surveillance versus immediate surgery for low-risk papillary thyroid microcarcinoma patients in south Korea: A cost-minimization analysis from the MAeSTro study[J].Thyroid,2022,32(6): 648-656.
21
董云伟,陈 革,陈曙光,等. 合并慢性淋巴细胞性甲状腺炎的甲状腺乳头状癌的临床病理特点及淋巴结转移风险分析[J]. 中华普通外科杂志,2019,34(3): 225-229.
22
Ding G,Qu X,Teng YGZ. A prospective randomized clinical study of minimally invasive video-assisted thyroidectomy for papillary thyroid microcarcinoma[J]. Surg Laparosc Endosc Percutan Tech,2023,33(5): 440-443.
23
武元元,范向达,王 军,等. cN0 期甲状腺乳头状微小癌大容量中央区淋巴结转移的危险因素[J]. 中国普通外科杂志,2019,28(11): 1361-1366.
24
Zhong J,Hu B. Occult follicular thyroid carcinoma with extensive systemic metastasis: a case report[J]. Int J Radiat Med Nucl Med,2023,47(11): 724-726.
25
Liu H,Li Y,Mao Y. Local lymph node recurrence after central neck dissection in papillary thyroid cancers:A meta analysis[J]. Eur Ann Otorhinolaryngol Head Neck Dis,2019,136(6): 481-487.
26
Dabas SK,Tiwari S,Ranjan R,et al. Occult thyroid carcinoma with cervical lymph node metastasis: A rare case report[J]. Indian J Otolaryngol Head Neck Surg,2024,76(4): 3566-3569.
27
Do KH,Sagalow ES,Wang R,et al. Two rare cases of metastatic occult thyroid carcinoma without primary cancer in the thyroid gland[J]. Cureus,2024,16(6): e63280.
28
Kimura A,Morioka S,Toyoda KI. Superficial cervical lymph node metastasis as the initial manifestation of occult papillary thyroid carcinoma: A case report[J]. Toukeibu Gan,2021,47(3): 337-341.
29
王 鑫,胡耀杰,郑 伟,等. 仅表现为侧颈淋巴结转移的隐匿性甲状腺癌1 例[J]. 中华耳鼻咽喉头颈外科杂志,2022,57(2): 215-216.
30
王照华,殷文斌. 甲状腺微小乳头状癌侧颈淋巴结转移相关危险因素与预测指标分析[J]. 中国普通外科杂志,2021,30(5):537-542.
[1] 黄晋杰, 李奕男, 王彩琴, 黄晓卉, 王荣昌. 结直肠癌肺转移术后复发性肺转移治疗进展[J/OL]. 中华普通外科学文献(电子版), 2025, 19(01): 50-54.
[2] 卢潼辉, 徐锋. 肝细胞癌肺转移的治疗现状[J/OL]. 中华普通外科学文献(电子版), 2022, 16(02): 141-145.
[3] 张峰, 谢良骏, 陈宇导, 程木华. 分化型甲状腺癌术后肺转移的SPECT/CT平面与断层显像诊断研究[J/OL]. 中华普通外科学文献(电子版), 2017, 11(05): 340-343.
[4] 周进军, 罗洪, 陈滔. 老年结直肠癌肺转移的CT特征及易发因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(04): 398-400.
[5] 陈荣, 钟鑫, 谭平, 张朋. 以阵发性腰痛、血尿、高血压为表现的右肾转移性副神经节瘤一例报告[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 172-174.
[6] 温盼, 李才坤, 何丹, 陈炎城. CT 引导活检与超声引导微波消融治疗直肠癌肺转移一例[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(01): 187-190.
[7] 余枝娟, 杨美, 张建勇. 以肺磨玻璃结节为表现的肺转移性恶性黑色素瘤一例[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(03): 445-447.
[8] 蒋雪, 刘恒, 何伟, 傅莉. 食道癌并发肺转移40例临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2021, 14(03): 363-365.
[9] 李彭媚, 刘刚, 李才弘, 刘长路, 黄婷, 刘娅, 刘代顺. 结肠癌术后经4年无病生存期转移至肺部1例[J/OL]. 中华肺部疾病杂志(电子版), 2019, 12(02): 249-250.
[10] 李春香, 刘恒昌, 赵志勋, 关旭, 姜争. 基于299例结直肠癌异时肺转移患者建立的预后评估模型[J/OL]. 中华结直肠疾病电子杂志, 2020, 09(01): 13-18.
[11] 程志远, 王俊男, 闫枫尚, 徐子恒, 徐拯, 辛诚, 楼征. 结直肠癌肺转移患者临床特征及预后影响因素分析——基于SEER数据库的回顾性研究[J/OL]. 中华结直肠疾病电子杂志, 2019, 08(03): 251-256.
[12] 中国医师协会外科医师分会多学科综合治疗专业委员会, 中国抗癌协会大肠癌专业委员会. 结直肠癌肺转移多学科综合治疗专家共识(2018版)[J/OL]. 中华结直肠疾病电子杂志, 2018, 07(06): 502-509.
[13] 李杰, 谢其根, 孙宗琼, 王卫国, 华燕艳. 碘125粒子植入治疗与立体定向放射治疗肠癌术后反复复发肺转移瘤的临床效果比较[J/OL]. 中华介入放射学电子杂志, 2018, 06(03): 216-221.
[14] 刘瑞宝. CT引导下125I粒子植入术后治疗肺转移瘤[J/OL]. 中华介入放射学电子杂志, 2018, 06(03): 0-0.
[15] 高坤, 郑燕. 结直肠癌术后肺转移的临床治疗决策[J/OL]. 中华胸部外科电子杂志, 2021, 08(01): 56-62.
阅读次数
全文


摘要